Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.

Jiang P, Wang P, Sun X, Yuan Z, Zhan R, Ma X, Li W.

Onco Targets Ther. 2016 Jun 13;9:3501-9. doi: 10.2147/OTT.S96278. eCollection 2016.

2.

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, Verma M, Kumar D.

Cancer Med. 2016 Aug;5(8):1917-46. doi: 10.1002/cam4.775. Epub 2016 Jun 10. Review.

3.

MicroRNA and extracellular vesicles in glioblastoma: small but powerful.

Rooj AK, Mineo M, Godlewski J.

Brain Tumor Pathol. 2016 Apr;33(2):77-88. doi: 10.1007/s10014-016-0259-3. Epub 2016 Mar 11.

PMID:
26968172
4.

CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo.

Chang H, Yi B, Ma R, Zhang X, Zhao H, Xi Y.

Sci Rep. 2016 Feb 29;6:22312. doi: 10.1038/srep22312.

5.

Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.

Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder S.

J Neurosci. 2015 Nov 11;35(45):15097-112. doi: 10.1523/JNEUROSCI.1265-15.2015.

6.

Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients.

LeBlanc VC, Morin P.

J Clin Med. 2015 Aug 14;4(8):1612-30. doi: 10.3390/jcm4081612. Review.

7.

MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours.

Garg N, Vijayakumar T, Bakhshinyan D, Venugopal C, Singh SK.

Stem Cells Int. 2015;2015:141793. doi: 10.1155/2015/141793. Epub 2015 May 3. Review.

8.

The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.

Auffinger B, Spencer D, Pytel P, Ahmed AU, Lesniak MS.

Expert Rev Neurother. 2015;15(7):741-52. doi: 10.1586/14737175.2015.1051968. Epub 2015 May 31. Review.

9.

Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.

Dahan P, Martinez Gala J, Delmas C, Monferran S, Malric L, Zentkowski D, Lubrano V, Toulas C, Cohen-Jonathan Moyal E, Lemarie A.

Cell Death Dis. 2014 Nov 27;5:e1543. doi: 10.1038/cddis.2014.509.

10.

Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology.

Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, Searles CD, Davis ME.

Circ Res. 2015 Jan 16;116(2):255-63. doi: 10.1161/CIRCRESAHA.116.304360. Epub 2014 Oct 24.

11.

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.

Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang S, Chen R, McLendon RE, Friedman AH, Keir ST, Bigner DD, Li QJ, Wang H, Wang XF.

J Clin Invest. 2014 Oct;124(10):4489-502. doi: 10.1172/JCI75284. Epub 2014 Sep 9.

12.

MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells.

Brower JV, Clark PA, Lyon W, Kuo JS.

Neurochem Int. 2014 Nov;77:68-77. doi: 10.1016/j.neuint.2014.06.002. Epub 2014 Jun 14. Review.

13.

Epigenetic dysregulation in glioma.

Kondo Y, Katsushima K, Ohka F, Natsume A, Shinjo K.

Cancer Sci. 2014 Apr;105(4):363-9. Review.

14.

Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.

Floyd DH, Zhang Y, Dey BK, Kefas B, Breit H, Marks K, Dutta A, Herold-Mende C, Synowitz M, Glass R, Abounader R, Purow BW.

PLoS One. 2014 May 7;9(5):e96239. doi: 10.1371/journal.pone.0096239. eCollection 2014.

15.

MYC and the art of microRNA maintenance.

Psathas JN, Thomas-Tikhonenko A.

Cold Spring Harb Perspect Med. 2014 Apr 15;4(8). pii: a014175. doi: 10.1101/cshperspect.a014175. Review.

16.

MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.

Henriksen M, Johnsen KB, Andersen HH, Pilgaard L, Duroux M.

Mol Neurobiol. 2014 Dec;50(3):896-913. doi: 10.1007/s12035-014-8668-y. Epub 2014 Mar 12. Review.

17.

Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation.

Katsushima K, Kondo Y.

Front Genet. 2014 Feb 3;5:14. doi: 10.3389/fgene.2014.00014. eCollection 2014. Review.

18.

Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.

Zhang Y, Kim J, Mueller AC, Dey B, Yang Y, Lee DH, Hachmann J, Finderle S, Park DM, Christensen J, Schiff D, Purow B, Dutta A, Abounader R.

Cell Death Differ. 2014 May;21(5):720-34. doi: 10.1038/cdd.2013.196. Epub 2014 Jan 17.

19.

MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications.

Stahlhut C, Slack FJ.

Genome Med. 2013 Dec 30;5(12):111. doi: 10.1186/gm516. eCollection 2013. Review.

20.

High-throughput microRNA profiling of pediatric high-grade gliomas.

Miele E, Buttarelli FR, Arcella A, Begalli F, Garg N, Silvano M, Po A, Baldi C, Carissimo G, Antonelli M, Spinelli GP, Capalbo C, Donofrio V, Morra I, Nozza P, Gulino A, Giangaspero F, Ferretti E.

Neuro Oncol. 2014 Jan;16(2):228-40. doi: 10.1093/neuonc/not215. Epub 2013 Dec 4.

Items per page

Supplemental Content

Write to the Help Desk